Reliance Chemotex Industries Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO’s 'Sell' rating for Reliance Chemotex Industries Ltd indicates a cautious stance for investors considering this stock. This rating suggests that, based on a comprehensive evaluation of the company’s quality, valuation, financial trend, and technical outlook, the stock is expected to underperform relative to the broader market or sector peers in the near to medium term. Investors are advised to carefully assess the risks before committing capital.

Rating Update Context

The rating was revised from 'Strong Sell' to 'Sell' on 25 August 2025, reflecting a modest improvement in the company’s overall mojo score, which increased by 3 points from 29 to 32. Despite this upgrade in rating category, the current 'Sell' status still signals significant concerns about the stock’s prospects. It is important to note that all financial data and performance metrics referenced here are current as of 10 February 2026, ensuring that investors have the latest information to inform their decisions.

Quality Assessment

As of 10 February 2026, Reliance Chemotex Industries Ltd’s quality grade remains below average. The company’s long-term fundamental strength is weak, with an average Return on Capital Employed (ROCE) of 9.25%. This level of capital efficiency is modest and indicates limited ability to generate strong returns on invested capital. Furthermore, the company’s net sales have grown at an annual rate of 8.44% over the past five years, while operating profit has increased at a rate of 17.83% annually. Although these growth rates are positive, they are not sufficiently robust to elevate the company’s quality standing within its sector.

Additionally, the company’s debt servicing capacity is a concern, with a high Debt to EBITDA ratio of 4.66 times. This elevated leverage ratio suggests that Reliance Chemotex Industries Ltd faces considerable financial risk, particularly in adverse market conditions, which weighs on its quality grade.

Valuation Perspective

From a valuation standpoint, the stock is currently rated as very attractive. This suggests that, relative to its earnings, assets, and sector peers, Reliance Chemotex Industries Ltd is trading at a discount that could appeal to value-oriented investors. However, the attractive valuation must be balanced against the company’s fundamental weaknesses and financial risks. Investors should consider whether the low price adequately compensates for the underlying challenges the company faces.

Financial Trend Analysis

The financial trend for Reliance Chemotex Industries Ltd is positive as of 10 February 2026. This indicates that recent financial metrics, such as revenue growth, profitability, or cash flow generation, have shown improvement or stability. Despite this, the company’s overall performance remains subdued when viewed over longer periods, as reflected in its stock returns and fundamental metrics.

Technical Outlook

The technical grade for the stock is bearish, signalling that market sentiment and price momentum are currently unfavourable. This is supported by the stock’s recent price performance: while it gained 2.29% on the latest trading day and 7.72% over the past week, it has declined by 2.19% over the last month and 9.46% over three months. More notably, the stock has delivered a negative return of 32.12% over the past year, underperforming the BSE500 index over one year, three years, and three months. This bearish technical outlook suggests that short-term price pressures remain a challenge for investors.

Stock Returns and Market Performance

As of 10 February 2026, Reliance Chemotex Industries Ltd’s stock returns present a mixed picture. The stock has shown some short-term resilience with a 0.41% gain year-to-date, but longer-term returns remain negative. The six-month return stands at -19.88%, and the one-year return is -32.12%. These figures highlight the stock’s struggles to generate positive returns for shareholders over extended periods, reinforcing the cautious stance implied by the 'Sell' rating.

Sector and Market Context

Operating within the Garments & Apparels sector, Reliance Chemotex Industries Ltd is classified as a microcap company. This classification often entails higher volatility and risk compared to larger, more established firms. The company’s below-average quality and bearish technical outlook, combined with its microcap status, suggest that investors should approach this stock with prudence, particularly given the competitive pressures and market dynamics within the apparel industry.

What This Rating Means for Investors

For investors, the 'Sell' rating on Reliance Chemotex Industries Ltd serves as a cautionary signal. It reflects a combination of below-average quality metrics, financial risks related to leverage, and a bearish technical outlook, despite the stock’s attractive valuation and some positive financial trends. Investors should carefully weigh these factors against their risk tolerance and investment horizon.

Those holding the stock may consider reviewing their positions in light of the company’s underperformance relative to broader market indices and sector peers. Prospective investors might find the valuation appealing but should remain mindful of the company’s fundamental challenges and the potential for continued price volatility.

Summary of Key Metrics as of 10 February 2026

• Mojo Score: 32.0 (Sell Grade)
• Quality Grade: Below Average
• Valuation Grade: Very Attractive
• Financial Grade: Positive
• Technical Grade: Bearish
• Debt to EBITDA Ratio: 4.66 times
• Return on Capital Employed (ROCE): 9.25%
• Annual Net Sales Growth (5 years): 8.44%
• Annual Operating Profit Growth (5 years): 17.83%
• Stock Returns: 1D +2.29%, 1W +7.72%, 1M -2.19%, 3M -9.46%, 6M -19.88%, YTD +0.41%, 1Y -32.12%

In conclusion, while Reliance Chemotex Industries Ltd shows some positive financial trends and an attractive valuation, the overall assessment points to significant risks and challenges. The 'Sell' rating reflects these realities, advising investors to exercise caution and conduct thorough due diligence before engaging with this stock.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →